Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures - Trial 2016-004951-55
Access comprehensive clinical trial information for 2016-004951-55 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Inc. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Eisai Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Median Percent Change From Baseline in All Partial Seizure Frequency (Complex Partial Seizures (CP)+ Simple Partial Seizures (SP) + Secondary Generalization Seizures (SGS)) During the Fixed-dose Phase
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2016-004951-55
Non-Device Trial